March 23, 2020 / 7:48 AM / 6 days ago

BRIEF-2Curex Provides Update Regarding The Covid-19 Impact On Ongoing Clinical Programs

March 23 (Reuters) - 2cureX AB:

* 2CUREX PROVIDES UPDATE REGARDING THE COVID-19 IMPACT ON ONGOING CLINICAL PROGRAMS

* 2CUREX AB - CORONA-CRISIS WILL NOT DELAY 2CUREX’S INTERVENTION STUDY WHERE INDITREAT TEST IS GUIDING TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER

* 2CUREX AB - PATIENT RECRUITMENT WILL CONTINUE AS PLANNED AND FINALIZATION OF TRIAL IS EXPECTED AS PREVIOUSLY COMMUNICATED IN Q3 OF 2020.

* 2CUREX AB - LATER STARTED 2CUREX CLINICAL PROGRAMS IN OVARIAN CANCER AND PANCREATIC CANCER WILL HOWEVER BE AFFECTED BY DELAYS

* 2CUREX AB - LENGTH OF THESE DELAYS IS NOT KNOWN PRESENTLY. Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below